PDCD1LG2 and neoplasm: Although PD-L1 and PD-L2 were differentially expressed in tumor tissue compared to healthy tissue, our UZA cohort overall showed a lower PD-L1 expression (both CPS and TPS) in comparison to the KEYNOTE trials (59, 60).